Top in ID: Impact of long COVID, pros and cons of an intranasal vaccine
Click Here to Manage Email Alerts
As experts continue to investigate long COVID, new research revealed that nonhospitalized COVID-19 survivors had a 60% increased risk for death after 30 days of illness.
An in-depth look at long COVID and the patients it affects, known commonly as “long-haulers,” was the top story in infectious disease last week.
Another top story featured an interview with Troy D. Randall, PhD, who spoke to Healio about the potential advantages and disadvantages of an intranasal COVID-19 vaccine.
Read these and more top stories in infectious disease below:
Long COVID: A ‘mysterious’ syndrome with ‘no clear pattern’ of symptoms
Among the many health consequences of COVID-19, there remain a few mysteries, including what causes the long-term, postacute sequelae known as long COVID. Read more.
Q&A: The case for an intranasal COVID-19 vaccine
According to scientists from the University of Alabama at Birmingham, only a small number of COVID-19 vaccines in development are given as nasal sprays, despite the technology’s potential to block SARS-CoV-2 transmission at the source. Read more.
Almost 8% of MSM globally have syphilis, study finds
The global prevalence of syphilis among men who have sex with men is close to 8%, according to the results of a study published recently in The Lancet Global Health. Read more.
Why is long COVID-19 reported more often among women than men?
As researchers try to determine who is most at risk for long COVID-19, evidence suggests that it is more common among women than men. Healio asked Sabra L. Klein, PhD, professor of molecular microbiology and immunology and co-director of the Center for Women’s Health, Sex, and Gender Research at the Johns Hopkins Bloomberg School of Public Health, about the disparity. Read more.
CDC updates STI treatment guidelines for first time since 2015
The CDC published updated clinical guidelines for the treatment of STIs amid a sustained national increase in cases of chlamydia, gonorrhea and syphilis. Read more.